Nymox Pharmaceutical Corporation
NYMXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,492 | -$8,844 | -$6,576 | -$12,537 |
| Dep. & Amort. | $1 | $11 | $12 | $12 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $671 | $3,357 | $593 | $2,603 |
| Change in WC | $1,219 | $821 | $495 | -$140 |
| Other Non-Cash | $0 | $598 | $509 | $3,027 |
| Operating Cash Flow | -$2,601 | -$4,057 | -$5,205 | -$9,820 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$3 | $0 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$3 | $0 | -$6 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,605 | $1,750 | -$229 | -$238 |
| Stock Issued | $0 | $1,150 | $6,007 | $7,283 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$173 | $0 | $0 |
| Financing Cash Flow | $2,605 | $2,727 | $5,778 | $7,045 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | $1,333 | $573 | -$2,781 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70 | -$1,403 | $830 | $3,611 |
| End Cash | $74 | -$70 | $1,403 | $830 |
| Free Cash Flow | -$2,601 | -$4,060 | -$5,205 | -$9,826 |